Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Health Aff (Millwood) ; 29(11): 2082-90, 2010 Nov.
Article in English | MEDLINE | ID: mdl-21041752

ABSTRACT

Current laws, practices, and concerns about privacy inhibit access to health data for research. Barriers include inconsistent Institutional Review Board policies and complicated and costly procedures to obtain the consent of patients for release of their information. To realize the promise of comparative effectiveness research, it is essential to develop a new policy framework that will allow and encourage the use of health information in all forms--fully identifiable, partially anonymized, and deidentified. We propose that health data be made available for information-based research under a so-called research safe harbor. The arrangement would include strict data security controls, standards, and practices to be promulgated by the secretary of health and human services, and an annual third-party audit to ensure compliance.


Subject(s)
Comparative Effectiveness Research/organization & administration , Confidentiality , Humans , Information Management/organization & administration , United States
2.
Sex Transm Dis ; 32(9): 521-5, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16118598

ABSTRACT

Neonatal herpes is a devastating disease, the most serious complication of genital herpes, one of the most common serious congenital or perinatal infections, and the most frequent complication of sexually transmitted infections among children. Nevertheless, neonatal herpes is not reportable to health authorities in most states. The potential for prevention has been enhanced by recent diagnostic and therapeutic advances, and the disease meets widely accepted criteria for reporting, including incidence rates that exceed those of comparable conditions, epidemiologic instability, disease severity, direct and indirect socioeconomic costs, concern by persons at risk, the potential for prevention by public health interventions, and the prospect that the resulting data would influence public health policy. The absence of national surveillance contributes to beliefs by healthcare providers and the public health community that genital and neonatal herpes are uncommon conditions that affect small segments of society, beliefs that directly interfere with prevention. Neonatal herpes should be a reportable condition.


Subject(s)
Herpes Simplex/prevention & control , Herpesvirus 1, Human , Herpesvirus 2, Human , Pregnancy Complications, Infectious/prevention & control , Antiviral Agents/administration & dosage , Central Nervous System/pathology , Eye/pathology , Female , Herpes Simplex/diagnosis , Herpes Simplex/drug therapy , Herpes Simplex/economics , Herpes Simplex/epidemiology , Humans , Infant, Newborn , Mass Screening , Mouth/pathology , Pregnancy , Pregnancy Complications, Infectious/diagnosis , Pregnancy Complications, Infectious/drug therapy , Pregnancy Complications, Infectious/economics , Pregnancy Complications, Infectious/epidemiology , Prenatal Care
SELECTION OF CITATIONS
SEARCH DETAIL
...